Table 1. Frequency of sequence validation in Ba/F3 transformation studies (2014-2016).
| Characteristics | PubMed Articles (%) | ||
|---|---|---|---|
| Publication Year | |||
| 2014 | 8 | (33) | |
| 2015 | 9 | (38) | |
| 2016 | 7 | (29) | |
| Search Term | |||
| Ba/F3 | 23 | (96) | |
| Baf3 | 1 | (4) | |
| Method of transduction | |||
| Retrovirus | 12 | (50) | |
| Lentivirus | 2 | (8) | |
| Electroporation | 6 | (25) | |
| Unclear | 4 | (17) | |
| Sequencing outgrown Ba/F3 lines | |||
| Transgene sequence confirmed | 0 | (0) | |
| Transgene not sequenced | 24 | (100) | |
Source: PubMed articles matching “Ba/F3” or “Baf3”, published 2014-2016, and using Ba/F3 cells for the purpose to establish transformative potential of genetic products. Data current as of 10-26-16.